These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 31606481)
1. Recent developments in the management of recurrent Clostridioides difficile infection. Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481 [TBL] [Abstract][Full Text] [Related]
2. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials. Madoff SE; Urquiaga M; Alonso CD; Kelly CP Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500 [TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation for treatment of patients with recurrent Voth E; Khanna S Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848 [TBL] [Abstract][Full Text] [Related]
5. Recurrent Clostridium difficile infection: From colonization to cure. Shields K; Araujo-Castillo RV; Theethira TG; Alonso CD; Kelly CP Anaerobe; 2015 Aug; 34():59-73. PubMed ID: 25930686 [TBL] [Abstract][Full Text] [Related]
6. Clostridioides Difficile: A Concise Review of Best Practices and Updates. Yakout A; Bi Y; Harris DM J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585 [TBL] [Abstract][Full Text] [Related]
7. The management of Clostridium difficile infection: antibiotics, probiotics and other strategies. Senok AC; Rotimi VO J Chemother; 2008 Feb; 20(1):5-13. PubMed ID: 18343738 [TBL] [Abstract][Full Text] [Related]
9. Recurrent Song JH; Kim YS Gut Liver; 2019 Jan; 13(1):16-24. PubMed ID: 30400734 [TBL] [Abstract][Full Text] [Related]
10. Current and future trends in clostridioides (clostridium) difficile infection management. Khanna S; Gerding DN Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313 [TBL] [Abstract][Full Text] [Related]
11. Advances in Khanna S Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1067-1070. PubMed ID: 33427531 [No Abstract] [Full Text] [Related]
12. Clostridioides difficile in transplant patients: early diagnosis, treatment, and prevention. Revolinski SL; Munoz-Price LS Curr Opin Infect Dis; 2019 Aug; 32(4):307-313. PubMed ID: 31116134 [TBL] [Abstract][Full Text] [Related]
13. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy. Mehta SR; Yen EF Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650 [TBL] [Abstract][Full Text] [Related]
14. Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II. Goldstein EJC; Citron DM; Gerding DN; Wilcox MH; Gabryelski L; Pedley A; Zeng Z; Dorr MB Clin Infect Dis; 2020 Aug; 71(4):1102-1105. PubMed ID: 31883370 [TBL] [Abstract][Full Text] [Related]
15. Cutting edges in Clostridioides difficile infections. Durovic A; Tschudin-Sutter S Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093 [TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Tan X; Johnson S Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233 [TBL] [Abstract][Full Text] [Related]